Background: Alzheimer’s disease (AD) involves complex molecular alterations in the cerebrospinal fluid (CSF) proteome, yet the links between these protein changes and hallmark AD pathology remain incompletely defined. We investigated the relationship between the CSF proteome with CSF biomarkers of Alzheimer’s disease (AD). Methods: CSF was collected in 500 individuals of non-Hispanic white, African Americans, and Caribbean Hispanic individuals.
Biomarker-informed CSF proteomics reveals ENPP2-LPA lipid signaling associated with Alzheimer's disease
calendar_today
July 10, 2026
person
Qiao, M., Bhattarai, P., Yilmaz, E., Rookyard, A., Das, L. A., Jain, A., Reyes-Dumeyer, D., Lee, A. J., Lantigua, R. A., Medrano, M., Rivera, D., Honig, L. S., Brown, L., Kizil, C., Mayeux, R., Vardarajan, B. N.
domain
medrxiv